Guru Ownership Trend
Guru Analysis for Prelude Therapeutics Incorporated (PRLD)
Prelude Therapeutics Incorporated (PRLD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.45 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $634,363 net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 50.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Prelude Therapeutics Incorporated (PRLD)
Major holders include Renaissance Technologies (RenTech) ($786,770), Steven Cohen ($171,587). According to the latest reported data, 2 tracked investment managers collectively hold approximately 330,468 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $634,363, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited PRLD. The total reported sell value was $805,950.
Yes, 1 managers opened new positions in PRLD, and 0 increased their existing holdings. The total reported buy value was $171,587.